Manuscripts

Search by keyword, year, or author name.

Showing 1552 manuscripts.

Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.

Z. A. Scott, Ellen Gould Chadwick, Lynn Gibson, Margaret McManus, Ram Yogev, Paul Palumbo, John L. Sullivan, Paula Britto, Hannah Gay, Katherine Luzuriaga. Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.. Journal of Immunology. 2002. 167: 7134-40.

Year

2002

Journal

Journal of Immunology

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche

Keith D. Chirgwin, Richard Hafner, Catherine Leport, Jack S. Remington, Janet Andersen, Elizabeth M. Bosler, Clemente Roque, Natasa Rajicic, Vincent J. McAuliffe, Philippe Morlat, Dushyantha T. Jayaweera, Jean-Louis Vilde, Benjamin J. Luft. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche. Clinical Infectious Diseases. 2002. 34: 1243-50. PMID: 11941551

Year

2002

Journal

Clinical Infectious Diseases

Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration

Jian-Feng Lu, Terrence F. Blaschke, Charles Flexner, Susan L Rosenkranz, Lewis Sheiner. Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration. Drug Metabolism and Disposition. 2002. 30: 1455-61.

Year

2002

Journal

Drug Metabolism and Disposition

A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy

Judith A. Aberg, Richard W. Price, Dorie M. Heeren, Barry Bredt. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. Journal of Infectious Diseases. 2002. 185: 1179-82.

Year

2002

Journal

Journal of Infectious Diseases

Safety of Two Recombinant HIV-1 Envelope Vaccines in Neonates Born to HIV-1 Infected Women

Coleen K. Cunningham, Diane W. Wara, Minhee Kang, Terence Fenton, Elizabeth Hawkins, James McNamara, Lynne M. Mofenson, Anne-Marie Duliege, Donald P. Francis, Donald P. Francis, Elizabeth (Betsy) J. McFarland, William Borkowsky. Safety of Two Recombinant HIV-1 Envelope Vaccines in Neonates Born to HIV-1 Infected Women. Clinical Infectious Diseases. 2002. 32: 801-807.

Year

2002

Journal

Clinical Infectious Diseases

Serologic Examination of Hepatitis B Infection and Immunization in HIV-Positive Youth and Associated Risks.

Adrienne Rogers, Jane C. Lindsey, Donna Futterman, Bonnie Zimmer, Susan Abdalian, Lawrence D'Angelo. Serologic Examination of Hepatitis B Infection and Immunization in HIV-Positive Youth and Associated Risks.. AIDS. 2002. 14: 651-657.

Year

2002

Journal

AIDS

Analysis of HIV-1 Drug Resistance in Children Receiving Nucleoside Analog Reverse Transcriptase Inhibitors Plus Nevirapine, Nelfinavir or Ritonavir.

Susan H. Eshleman, Paul Krogstad, Brooks Jackson, YouGan Wang, Sabina Lee, Lee-Jen Wei, Coleen K. Cunningham, Michael Wantman, Andrew A. Wiznia, George M. Johnson, Sharon Appelbaum Nachman, Paul Palumbo. Analysis of HIV-1 Drug Resistance in Children Receiving Nucleoside Analog Reverse Transcriptase Inhibitors Plus Nevirapine, Nelfinavir or Ritonavir.. Journal of Infectious Diseases. 2002. 1732-1708.

Year

2002

Journal

Journal of Infectious Diseases

Vertical transmission of Subtype D and Subtype A/G Human Immunodeficiency virus in the United States.

Paul Krogstad, Susan H. Eshleman, Jennifer Jackson, Michael Wantman, Bette T. Korber, Andrew A. Wiznia, George M. Johnson, Sharon Appelbaum Nachman, Paul Palumbo. Vertical transmission of Subtype D and Subtype A/G Human Immunodeficiency virus in the United States.. AIDS Research and Human Retroviruses. 2002. 18: 413-417.

Year

2002

Journal

AIDS Research and Human Retroviruses

Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316.

Coleen Cunningham, Marie-Laure Chaix, Claire Rekacewicz, Paula Britto, Christine Rouzioux, Richard D. Gelber, Alejandro Dorenbaum, Jean-Francois Delfraissy, B. Brazin, Lynne M. Mofenson, John L. Sullivan, John P. Sullivan. Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316.. Journal of Infectious Diseases. 2002. 186: 181-8.

Year

2002

Journal

Journal of Infectious Diseases

Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.

A. Saitoh, Terence Fenton, Karen Hsia, Christine Powell, Cindy Christopherson, Courtney V. Fletcher, Stuart E. Starr, Stephen A. Spector. Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.. Journal of Infectious Diseases. 2002. 185: 1409-16.

Year

2002

Journal

Journal of Infectious Diseases